If you have any questions about clinical research at East Florida Eye Institute, or are interested in participating in a clinical trial, please contact us using this form
You may also submit your contact information and diagnosis if you would like to be contacted for a future clinical trial.
Post- Cataract Surgery
A trial is available for adults who will be OR HAVE RECENTLY HAD cataract surgery. The purpose of this study is to assess the efficacy and safety of ISV-305 in patients with pain and inflammation post-cataract surgery. Total study duration is 29 days.
RVL-1201 202/203 Ptosis
TWO TRIALS ARE AVaILABLE for adults who have been diagnosed with acquired blepharoptosis (ptosis).
The purpose of THE FIRST study is to assess the efficacy and safety of RVL-1201 versus A placebo. THE dosing period OF THIS STUDY is 6 weeks. Total study duration is 8 weeks.
The purpose of thE SECOND study is to access the EFFICACY AND safety of RVL-1201 versus A placebo over an extended dosing period of 12 weeks. Total duration of study is 84 days.
a trial is available for anyone over the age of 50 that has subfoveal cnv lesions secondary to amd. the purpose of this study is to evaluate the safety and efficacy of conbercept ivt compared to aflibercept in patients with wet amd. total study duration is 96 weeks
Glaucoma Clinical Trial
A trial is available for anyone over the age of 18 with OAG or OHT. The purpose of this study is to control glaucoma by injecting sustained release Bimatoprost into the anterior chamber about every 4 months compared to Selective Laser Trabeculoplasty, or SLT. Total study duration is 1 year